Ultragenyx Pharmaceutical Other Non-Current Liabilities 2012-2024 | RARE
Ultragenyx Pharmaceutical other non-current liabilities for the quarter ending June 30, 2024 were $0.857B, a 3.82% decline year-over-year.
- Ultragenyx Pharmaceutical other non-current liabilities for 2023 were $0.875B, a 0.65% decline from 2022.
- Ultragenyx Pharmaceutical other non-current liabilities for 2022 were $0.88B, a 148.48% increase from 2021.
- Ultragenyx Pharmaceutical other non-current liabilities for 2021 were $0.354B, a 3.28% increase from 2020.